Research Article

Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer

Table 5

Comparison of tumor markers in blood between the two groups before and after treatment ( ± s).

GroupCA125 (U/ml) valueCA199 (IU/ml) valueCA724 (IU/ml) value
Before treatmentAfter treatmentBefore treatmentAfter treatmentBefore treatmentAfter treatment

Control group48.32 ± 12.3225.64 ± 6.150.01281.23 ± 7.3653.21 ± 3.640.00434.68 ± 4.6114.56 ± 4.80.006
Observation group49.12 ± 11.1318.45 ± 3.140.00380.64 ± 6.4541.54 ± 4.65<0.00135.48 ± 6.489.12 ± 4.71<0.001
value0.8210.0270.7540.0180.6340.035